Culture of Hansen's bacilli in vitro in a case of lepromatous leprosy.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 347183)

Published in Mater Med Pol on June 28, 1978

Authors

W K Massalski, R R Shukla, W Lewenstein, R Wierzbicki

Articles by these authors

Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup. Lancet (1997) 2.33

Epirubicin in extensive small-cell lung cancer: a phase II study in previously untreated patients: a National Cancer Institute of Canada Clinical Trials Group Study. J Clin Oncol (1990) 1.16

Phase II study of amonafide: results of treatment and lessons learned from the study of an investigational agent in previously untreated patients with extensive small-cell lung cancer. J Clin Oncol (1990) 1.13

Inhibition of pre-mRNA splicing by 5-fluoro-, 5-chloro-, and 5-bromouridine. J Biol Chem (1989) 1.04

Cell cycle-dependent stimulation of the HIV-1 promoter by Tat-associated CAK activator. Virology (2000) 0.99

Phase I-II study of high-dose epirubicin in advanced non-small-cell lung cancer. J Clin Oncol (1992) 0.91

A human primary T-lymphocyte-derived human immunodeficiency virus type 1 Tat-associated kinase phosphorylates the C-terminal domain of RNA polymerase II and induces CAK activity. J Virol (1997) 0.91

Blood coagulation changes in rats poisoned with methylmercuric chloride (MeHg). Pol J Pharmacol Pharm (1990) 0.87

Inhibition of HIV-1 replication in viral mutants with altered TAR RNA stem structures. Virology (1996) 0.87

Interaction of nuclear protein p140 with human immunodeficiency virus type 1 TAR RNA in mitogen-activated primary human T lymphocytes. J Virol (1995) 0.81

Content of mercury in chromatin and level of metallothionein proteins in kidneys and liver of rats. Biochem Pharmacol (1981) 0.81

Binding of mercury by chromatin of rats exposed to mercuric chloride. Environ Res (1979) 0.81

Cyclin D1 protein and CCND1 gene expression in colorectal cancer. Eur J Surg Oncol (2005) 0.80

Chicken reticulocyte nuclear antigen: its identification and relation to transcriptive activity in erythropoietic cells. Biochemistry (1980) 0.80

Effect of mercuric chloride on cultured rat fibroblasts: survival, protein biosynthesis and binding of mercury to chromatin. Biochem Pharmacol (1983) 0.80

Interaction of human immunodeficiency virus type I Rev protein with nuclear scaffold nucleoside triphosphatase activity. Cell Growth Differ (1991) 0.80

Usefulness of polyclonal antibodies raised against P65 oncofetal protein in immunohistochemical diagnosis of ductal breast cancer. J Exp Clin Cancer Res (2004) 0.80

Coagulation and fibrinolysis in rats poisoned with mercuric chloride. Pol J Pharmacol Pharm (1989) 0.80

Expression of p65, DD3 and c-erbB2 genes in prostate cancer. Neoplasma (2003) 0.80

p65 and c-erbB2 genes expression in breast tumors: comparison with some histological typing, grading and clinical staging. J Exp Clin Cancer Res (2003) 0.79

Developmental pattern of DNA and proteins in brain, liver, lung and heart of rats given excess vitamin A postnatally. Biol Neonate (1983) 0.79

In vitro secretion and uptake of radioactive vitamin A in rats fed different dietary proteins. Ann Nutr Metab (1987) 0.78

VP-16, ifosfamide and cisplatin (VIP) for extensive small cell lung cancer. Eur J Cancer (1994) 0.78

Phase II trials of trimetrexate in advanced adult soft tissue sarcoma. Studies of the Canadian Sarcoma Group and the National Cancer Institute of Canada Clinical Trials Group. Ann Oncol (1991) 0.78

A phase II study of recombinant tumor necrosis factor in renal cell carcinoma: a study of the National Cancer Institute of Canada Clinical Trials Group. J Immunother (1991) (1992) 0.78

Procoagulant activity of human stomach and colon cancers. Oncology (1990) 0.77

A phase II study of VP-16 and cisplatin in patients with unresectable malignant mesothelioma. An NCI Canada Clinical Trials Group Study. Invest New Drugs (1988) 0.76

[On selective semicarbonization of steroid ketones]. Acta Pol Pharm (1968) 0.75

Vulvar sarcoma: a report of four cases. Gynecol Oncol (1992) 0.75

Effect of pretreatment with cancerous cells on the growth of Brucella. Indian J Exp Biol (1973) 0.75

Impaired Myelination in rats given excess vitamin A postnatally. Int J Vitam Nutr Res (1983) 0.75

Vitamin A and biochemical development. II. Effect of postnatal excess vitamin-A administration on the activity of pyridine nucleotide-linked dehydrogenases. Biol Neonate (1984) 0.75

Fibrinolytic inhibitors from the experimental rat epithelioma. Thromb Res (1989) 0.75

A 65 kDa oncofetal protein (p65), proliferating cell nuclear antigen (PCNA) and Ki67 expression in breast cancer patients. Neoplasma (1998) 0.75

Non-histone chromatin proteins during maturation of avian erythroid cells. Acta Biochim Pol (1976) 0.75

An ovarian condition with multiple cystic follicles in a hen. Vet Rec (1979) 0.75

Scanning electron microscopic study on the influence of mercury compounds on the rat erythrocytes. Acta Med Pol (1980) 0.75

YMn2Hx and RMn(2-y)Fe(y)H6 (R = Y, Er) studied by Raman, infrared and inelastic neutron scattering spectroscopies. Faraday Discuss (2011) 0.75

Plasminogen activator (PA) in Guerin epithelioma. Additional PA inhibitor in plasma of rats bearing the epithelioma. Neoplasma (1990) 0.75

Plasma and platelet fibrin-stabilizing factor activity in rats intoxicated with phenylmercuric acetate. Pol J Pharmacol Pharm (1985) 0.75

[Specific inhibitors of plasminogen activators]. Postepy Hig Med Dosw (1993) 0.75

Observations on some streptococci infections in piglets and prophylactic measures adopted in a pig farm in Lubumbashi. Bull Anim Health Prod Afr (1978) 0.75

Phase II study of 2'-deoxycoformycin in patients with renal cell carcinoma. A National Cancer Institute of Canada Clinical Trials Group study. Invest New Drugs (1991) 0.75

Skin reactions to selected antigens in patients with leprosy. Mater Med Pol (1983) 0.75

Expression of 65-kDa oncofetal protein in experimental hepatoma after anticancer therapy. Neoplasma (1997) 0.75

Vitamin A and biochemical development. I. Effect of postnatal excess vitamin-A administration on lipogenesis in various organs of the rat. Biol Neonate (1984) 0.75

Structural and magnetic properties of DyMn(2)D(6) synthesized under high deuterium pressure. J Phys Condens Matter (2008) 0.75

Formation of hydrides in (Ti(1-x)Zr(x))Co(2.00) (0 < x < 1) pseudobinary alloys. Inorg Chem (2009) 0.75

[Pulmonary emboli during tropical pyomyositis. Proposal of a preventive treatment]. Nouv Presse Med (1977) 0.75

Placental transfer of metals of coal fly ash into various fetal organs of rat. Arch Toxicol (1990) 0.75

[Attempts of use of 1,3-dichloro-5,5-dimethylhydantoin (dichlorantin) in reactions of chlorination of 4-3-ketosteroids]. Acta Pol Pharm (1969) 0.75

Effect of methylmercuric chloride (MMC) on fibrin polymerization. Biol Trace Elem Res (1993) 0.75

Fibrinolytic activity of rat plasma during development of Guerin epithelioma. Cancer Lett (1990) 0.75

Trials of culturing of Mycobacterium leprae using media enriched with thyroid hormones. Mater Med Pol (1986) 0.75

Glycosylation of serum HDL and LDL in rats given excess retinol. Int J Vitam Nutr Res (1981) 0.75

5-Fluorouracil with folinic acid is not effective against metastatic adenocarcinoma of the lung. Cancer Invest (1990) 0.75

Immunospecificity of nuclear antigens in chicken erythroid cells. Mol Cell Biochem (1980) 0.75

[The mitochondrial deoxyribonucleic acid]. Postepy Biochem (1966) 0.75

Low molecular weight fibrinolytic inhibitor from Guerin epithelioma. Cancer Lett (1989) 0.75

[Fast-acting plasminogen activator inhibitor in the plasma]. Postepy Hig Med Dosw (1989) 0.75

Studies of Johne's disease. Studies on the various antigens of Mycobacterium paratuberculosis by agar-gel precipitation test. Indian Vet J (1967) 0.75

Malignant cystosarcoma phyllodes: A review of the clinical experience at King Faisal Specialist Hospital and Research Centre. Ann Saudi Med (1994) 0.75

[Plasminogen activator inhibitors from neoplastic tissues]. Postepy Hig Med Dosw (1991) 0.75

Phosphatidyl N-methylethanolamine in rat brain. Indian J Biochem Biophys (1982) 0.75

Interaction of fibrinogen with mercury. Thromb Res (1983) 0.75

Proteolytic degradation of histones of ox pancreas. Bull Acad Pol Sci Biol (1977) 0.75

[Plasminogen activators in tumor tissue]. Pol Arch Med Wewn (1989) 0.75

Letter: Culture of M. leprae with help of desiccated thyroid. Lancet (1976) 0.75

Studies on histones and nuclear phosphoproteins of rat liver and Morris hepatoma. Acta Biochim Pol (1976) 0.75

Immunohistochemical analysis of expression of a 65 kDa oncofetal protein (p65), epidermal growth factor receptor (EGFR), oncogene c-erb B2 and tumor suppressor gene p53 protein products in breast cancer patients. Neoplasma (2000) 0.75

Blood coagulation changes in rats during development of epithelioma. Neoplasma (1989) 0.75

Placental transfer and fetal distribution of 3H-retinoic acid in rats. Int J Vitam Nutr Res (1986) 0.75

Activity of neutral chromatin protease during maturation of chicken erythroid cells. Biochimie (1976) 0.75

Uptake of radiolabeled morphiceptin and its analogs by experimental mammary adenocarcinoma: in vitro and in vivo studies. Nucl Med Biol (2004) 0.75

In-vitro modulation of protein kinase C activity by environmental chemical pollutants. Biochem Biophys Res Commun (1987) 0.75

[Separation, identification and comparative evaluation of adrenal steroids in urine extracts using thin-layer chromatography]. Pol Arch Med Wewn (1966) 0.75

Cancer procoagulant in serum of rats during development of experimental epithelioma. Int J Cancer (1990) 0.75

Factor X-activating activity from Guerin epithelioma. Neoplasma (1988) 0.75

A late relapse of primary Krukenberg tumour with bone metastases. Clin Oncol (R Coll Radiol) (2003) 0.75

Arthritis in pigs from farms of the Shaba region of Zaire. Bull Anim Health Prod Afr (1978) 0.75

Selective extraction of histones from normal and irradiated calf lymph-nodes. Int J Radiat Biol Relat Stud Phys Chem Med (1971) 0.75